Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-02

Clinical Trial Update: Nebulized Bupivacaine Analgesia for Cleft Palate Repair [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nebulized bupivacaine analgesia for cleft palate repair is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (nebulized) (bupivacaine)

Snippet

Sponsor: Assiut University | Conditions: Cleft Palate | Phase 3 | Status: RECRUITING